HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

Leo A Di; B Lesperance; S Korec; J Crown; P Simmonds; G von Minckwitz; JY Leroy; V Durbecq; J Isola; M Aapro; MJ Piccart; S Chan; D Larsimont; M Paesmans; K Friedrichs; T Pinter; V Cocquyt; E Murray; I Bodrogi; E Walpole

doi:10.1023/b:brea.0000036783.88387.47

HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

Leo A Di
, B Lesperance
, S Korec
, J Crown
, P Simmonds
, G von Minckwitz
, JY Leroy
, V Durbecq
, J Isola
, M Aapro
, MJ Piccart
, S Chan
, D Larsimont
, M Paesmans
, K Friedrichs
, T Pinter
, V Cocquyt
, E Murray
, I Bodrogi
, E Walpole

Department of Clinical Chemistry

Research output: Contribution to journal › Article › Scientific › peer-review

57 Citations (Scopus)

Original language	English
Pages (from-to)	197-206
Journal	Breast Cancer Research and Treatment
Volume	86
Issue number	3
DOIs	https://doi.org/10.1023/b:brea.0000036783.88387.47
Publication status	Published - 2004
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1023/b:brea.0000036783.88387.47

Cite this

Di, L. A., Lesperance, B., Korec, S., Crown, J., Simmonds, P., von Minckwitz, G., Leroy, JY., Durbecq, V., Isola, J., Aapro, M., Piccart, MJ., Chan, S., Larsimont, D., Paesmans, M., Friedrichs, K., Pinter, T., Cocquyt, V., Murray, E., Bodrogi, I., & Walpole, E. (2004). HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel. Breast Cancer Research and Treatment, 86(3), 197-206. https://doi.org/10.1023/b:brea.0000036783.88387.47

@article{83fe425ca64b4150b53d8f68916b269d,

title = "HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel",

author = "Di, \{Leo A\} and B Lesperance and S Korec and J Crown and P Simmonds and \{von Minckwitz\}, G and JY Leroy and V Durbecq and J Isola and M Aapro and MJ Piccart and S Chan and D Larsimont and M Paesmans and K Friedrichs and T Pinter and V Cocquyt and E Murray and I Bodrogi and E Walpole",

year = "2004",

doi = "10.1023/b:brea.0000036783.88387.47",

language = "English",

volume = "86",

pages = "197--206",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "3",

}

Di, LA, Lesperance, B, Korec, S, Crown, J, Simmonds, P, von Minckwitz, G, Leroy, JY, Durbecq, V, Isola, J, Aapro, M, Piccart, MJ, Chan, S, Larsimont, D, Paesmans, M, Friedrichs, K, Pinter, T, Cocquyt, V, Murray, E, Bodrogi, I & Walpole, E 2004, 'HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel', Breast Cancer Research and Treatment, vol. 86, no. 3, pp. 197-206. https://doi.org/10.1023/b:brea.0000036783.88387.47

TY - JOUR

T1 - HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel

AU - Di, Leo A

AU - Lesperance, B

AU - Korec, S

AU - Crown, J

AU - Simmonds, P

AU - von Minckwitz, G

AU - Leroy, JY

AU - Durbecq, V

AU - Isola, J

AU - Aapro, M

AU - Piccart, MJ

AU - Chan, S

AU - Larsimont, D

AU - Paesmans, M

AU - Friedrichs, K

AU - Pinter, T

AU - Cocquyt, V

AU - Murray, E

AU - Bodrogi, I

AU - Walpole, E

PY - 2004

Y1 - 2004

U2 - 10.1023/b:brea.0000036783.88387.47

DO - 10.1023/b:brea.0000036783.88387.47

M3 - Article

SN - 0167-6806

VL - 86

SP - 197

EP - 206

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 3

ER -